JAK2 and myeloproliferative neoplasm: Conditional knockout of JAK2 leads to bone marrow failure, increased apoptosis, and loss of quiescence in HSC-enriched cells.32,50,51 On the other hand, gain-of-function (GOF) mutations in JAK2 are specifically associated with myeloproliferative neoplasms (MPNs).